Mark A. Findeis
31Patents
10h-index
57Co-inventors
78Inventor score
Filing activity: Feb 28, 1995 → Mar 21, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5854204A | A.beta. peptides that modulate .beta.-amyloid aggregation | Human Necessities | 118 | Expired |
| US6303567A | Modulators of .beta.-amyloid peptide aggregation comprising D-amino acids | Human Necessities | 89 | Expired |
| US5817626A | Modulators of beta-amyloid peptide aggregation | Human Necessities | 87 | Expired |
| US5854215A | Modulators of .beta.-amyloid peptide aggregation | Human Necessities | 70 | Expired |
| US5985242A | Modulators of .beta.-amyloid peptide aggregation comprising D-amino acids | Human Necessities | 64 | Expired |
| US6214795A | Peptide compounds useful for modulating FGF receptor activity | Human Necessities | 45 | Expired |
| US5972890A | Synthetic peptides for arterial imaging | Human Necessities | 42 | Expired |
| US6319498A | Modulators of amyloid aggregation | Human Necessities | 36 | Expired |
| US5726153A | Synthetic peptides for arterial imaging | Human Necessities | 15 | Expired |
| US6277826A | Modulators of .beta.-amyloid peptide aggregation comprising D-amino acids | Physics | 13 | Expired |
| US5955055A | Synthetic peptides for arterial imaging at vascular imaging sites | Human Necessities | 9 | Expired |
| US7049395B2 | Anti-inflammatory compounds and uses thereof | Human Necessities | 8 | Expired |
| US6610658B1 | Modulators of &mgr;-amyloid peptide aggregation | Human Necessities | 7 | Expired |
| US6689752B2 | Modulators of &bgr;-amyloid peptide aggregation comprising D-amino acids | Physics | 6 | Expired |
| US6831066B2 | Modulators of &bgr;-amyloid peptide aggregation | Human Necessities | 5 | Expired |
| US7534858B2 | Anti-inflammatory compounds and uses thereof | Human Necessities | 5 | Expired |
| US7851641B2 | Compounds useful for treating neurodegenerative disorders | Chemistry; Metallurgy | 4 | Active |
| US7658917B2 | Modulators of amyloid aggregation | Human Necessities | 4 | Expired |
| US10912831B1 | Anti-CTLA-4 antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US7175828B2 | Modulators of β-amyloid peptide aggregation comprising D-amino acids | Physics | 3 | Expired |
| US11013802B2 | Anti-CTLA-4 antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US11638755B2 | Anti-CTLA-4 antibodies and methods of use thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US7812118B2 | Anti-inflammatory compounds and uses thereof | Human Necessities | 1 | Active |
| US11993653B2 | Antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11098117B2 | Anti-CD137 antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.